Among the clinically high-risk sub-population, there were 14 events out of 42 genetically high-risk subjects defined by the 23-gene classifier, while only 2 events were observed during the 5-year follow up period from 137 genetically low-risk subjects predicted by the signature, resulting in a highly significant p -value of 0.0001 ( Figure 5 ).
← all excerpts
Comparing Genetic Risk and Clinical Risk Classification in Luminal-like Breast Cancer Patients Using a 23-Gene Classifier.
1
—
—